Technological Innovations in Osteoporosis Diagnosis and their Implications for Bone Metastases Management in Oncology

Advances in technology are revolutionizing osteoporosis diagnosis, with significant implications for managing bone metastases in oncology. This review examines cutting-edge diagnostic innovations, including high-resolution imaging techniques like peripheral quantitative computed tomography (HR-pQCT), and their role in detecting subtle changes in bone microarchitecture. It highlights the integration of artificial intelligence (AI) and machine learning for improving diagnostic precision, particularly in distinguishing between osteoporotic fractures and cancer- induced bone damage. Furthermore, the paper explores the intersection of osteoporosis and oncology, focusing on how emerging technologies can facilitate early detection of metastatic bone disease, enhance treatment planning, and improve patient outcomes. By bridging the fields of osteoporosis diagnosis and oncology, this study emphasizes the need for interdisciplinary approaches to address shared challenges in bone health. Future directions for research and clinical applications are also discussed, paving the way for innovations that could transform patient care in both domains.